More recently, Ström et al. examined the ratio of Tregs with regulatory capabilities (Foxp3+/CD4+CD25bright) in COPD smokers, alongside healthy smokers and control groups [32]. This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.